AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CTRE

CareTrust REIT Inc. Common Stock (CTRE) fair value

Real Estate · REIT - Healthcare Facilities · NYSE · United States
$36.62+0.00%
Market cap $8.7BNext earnings 2026-11-04Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 75% above our fair value
Price
$36.62
Model fair valueConfidence: good
$20.96
Model range
$18.02 to $24.51
Fair value $20.96
Price $36.62
3 models fit CareTrust REIT Inc. Common Stock and they partly agree: 2 of 3 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a REIT (property company): Price to FFO, Dividend discount, and EV/EBITDA comparison.
ACCE opinionCareTrust REIT Inc. Common Stock (CTRE)
Fair value (3 models)
$20.96
ACCE price target
$37.00
Rating
Overvalued
Horizon
12 months
Fair value published on 10 Oct 2026, 00:00 CEST; previously $27.27 since 21 Sept 2026, 00:00 CEST.
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 17:05 CEST.
Price used: $36.62 at the close on 23 Oct 2026, 22:00 CEST.
Models: Dividend discount, EV/EBITDA comparison, and Price to FFO.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
74.7% above
-42.8% to fair value
ACCE score
66
out of 100
Analysts
92% buy
13 covering
P/E
22.9x
forward 20.8x
1-year return
+4.8%
Dividend yield
4.26%

CareTrust REIT Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

CareTrust REIT owns and leases skilled nursing, senior housing and behavioral health facilities, collecting rent from operators under long-term triple-net leases that push most property costs onto the tenant. That structure explains the 96.4% gross margin and 64.9% operating margin, which are unusually high even for a REIT. Revenue growth of 43.5% is the headline, but it reflects acquisitions funded by new capital, so the durable question is whether rent coverage from operators holds up as they carry their own cost and staffing pressure. The stock trades at 22.9 times trailing earnings and 21.3 times forward, a modest premium for a sector where the market pays for predictable cash flow. With an 8.6 billion dollar market cap and a 66 out of 100 score, the name is worth a closer look at tenant coverage ratios and the pace of acquisitions before deciding whether the growth is being bought at a fair price.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Valuation stretched vs model
    Price trades 74.7% above the model fair value of $20.96, and the forward P/E of 21.3 and EV/EBITDA of 18.8 leave little margin for error.
  • moderate
    Earnings growth lags revenue
    Revenue grew 43.5% year over year, but earnings grew only 8.6%, so the top-line growth is not yet converting to profit at the same rate.

AI research notes

AI-assisted·How I use AIWritten Oct 21, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 43.5% year over year, well ahead of its 22.1% average annual pace over five years.
  • Analysts are overwhelmingly positive, with 12 of 13 rating the stock Buy or Strong Buy, and their mean target sits 19.9% above the price.
  • A 4.0% dividend yield pays shareholders well while the company waits for growth to show up in per-share results.
Why it could disappoint
  • The stock trades 74.7% above the model fair value of $20.96, and all three valuation models point to a lower price.
  • Growth has come largely from buying assets, with the diluted share count rising 31.5% in the last fiscal year.
  • Returns are thin, with return on equity at 9.1% and return on invested capital at 5.3%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CTRE's valuation models land
Price
$36.62
Model fair value
$20.96
Model range
$18.02 to $24.51
Fair value $20.96
Price $36.62
The price is above the whole model range.
Model
Fair value
Upside
Dividend discount
EV/EBITDA comparison
Price to FFO
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish92% buy · 13 covering analysts
● Strong buy 10● Buy 2● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.2%
1 month
-1.5%
3 months
-15.3%
6 months
-3.5%
YTD
+1.3%
1 year
+4.8%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 17:05 CESTRatingOvervaluedfirst publication$36.55
10 Oct 2026, 00:00 CESTFair value$21.05$27.27$35.79
10 Oct 2026, 00:00 CESTACCE price target$37.00first publication$35.79
21 Sept 2026, 00:00 CESTFair value$27.27$27.74$37.54
19 Sept 2026, 00:00 CESTFair value$27.74$27.45$38.17
16 Sept 2026, 00:00 CESTFair value$27.45$28.71$38.11
11 Sept 2026, 00:00 CESTFair value$28.71$29.13$39.04
5 Sept 2026, 00:00 CESTFair value$29.13$29.85$39.61
31 Aug 2026, 00:00 CESTFair value$29.85$30.23$39.03
25 Aug 2026, 00:00 CESTFair value$30.23$29.71$39.72

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CTRE page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth84Value49Quality85Momentum47Total66
Valuation
Trailing P/E
22.9x
Forward P/E
20.8x
PEG
2.59
P/B
1.96x
EV / Revenue
22.0x
Book value/sh
$19.03
Enterprise value
$9.9B
Profitability
ROE
9.1%
FCF yield
4.50%
ROIC
5.3%
Health and risk
Debt / equity
0.22
Dividend yield
4.26%
Beta
0.77

Price

+4.1% · 1Y

Ask anything about CTRE

Answered from CareTrust REIT Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 60% of peers
low 16.5x22.9xhigh 79.1x
ROEbetter than 67% of peers
low -2%9%high 17%
Div yieldbetter than 17% of peers
low 1.9%4.3%high 6.3%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CTRE CareTrust REIT Inc. Common Stock$36.62$2175% above22.9x9.1%8566
AHR American Healthcare REIT Inc. Common Stock$53.40--79.1x4.0%4356
HR Healthcare Realty Trust Incorporated Common Stock$17.93$1165% above--1.9%4736
DOC Healthpeak Properties Inc. Common Stock$19.34--55.0x3.0%5761
OHI Omega Healthcare Investors Inc. Common Stock$46.30$3628% above16.5x16.5%8168
SBRA Sabra Health Care REIT Inc. Common Stock$19.60--78.2x2.4%4445
NHI National Health Investors Inc. Common Stock$66.96$5425% above18.8x10.7%8168

Sector report card

Where CTRE ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 9, 2026
    CareTrust Publishes Sixth Annual Corporate Sustainability Report
  • Business Wire•Oct 2, 2026
    CareTrust Announces Strategic SHOP Pipeline Agreement with LNT Care Developments to Acquire 45 New UK Care Homes for £1.1 Billion
  • Business Wire•Sep 15, 2026
    CareTrust REIT Announces Quarterly Dividend of $0.39 per Share
4 more press releases · full archive on Investor+.INVESTOR
29 filings of 35
October 2026
Oct 2
8-KCurrent reportPeriod 2026-09-30
View on SEC →
August 2026
Aug 6
8-KCurrent reportPeriod 2026-08-06
View on SEC →
Aug 6
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
26 more filings + AI summaries on Investor+.INVESTOR